Remix Therapeutics

0 followers


Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.

Employees

11-50

Links

Org chart

Peter Smith
Co-Founder, & CEO

Peter Smith

Collapse
Heather Wasserman
COO & Chief Business Officer
Cecile Blaustein
VP, Program Management
Mark Scuzzarella
VP, Human Resources
Matthew Schnaderbeck
Sr. Director, CMC
Benoît Moreau
Head, Medicinal Chemistry

Board & advisors

Scott Biller
Director
Michael Rome
Director
Angela Brooks
Scientific Advisor
Christopher Burge
Scientific Advisor
Benoit Chabot
Scientific Advisor
Ryan Corcoran
Scientific Advisor
Will Fairbrother
Scientific Advisor
Aaron Hoskins
Scientific Advisor
Juan Valcarcel
Scientific Advisor
Rui Zhao
Scientific Advisor
Jeff Goater
Director